Osteoarthritis Trial, Recruiting NCT05067543 Sponsor: Stryker Trauma and Extremities Condition: Osteoarthritis
Back to Osteoarthritis

Osteoarthritis Trial, Recruiting

NCT05067543
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You are 18 years old or older at the time of signing up for the study
  • You are willing and able to read and sign a consent form agreeing to take part
  • You are able and willing to follow all the steps and requirements of the study
  • Your doctor has decided that you are a suitable candidate for shoulder replacement surgery using the device being studied
  • You meet the medical requirements for using this type of shoulder replacement device in your country or region

Who may not be able to join:

  • You are not able to follow the study procedures, for example if you have difficulty understanding study questions or cannot attend scheduled appointments
  • You belong to a group considered vulnerable, such as anyone under 18, anyone who cannot make their own decision to participate, or anyone who may feel pressured into joining
  • You currently have an active infection in your body or bones (such as a bone infection called osteomyelitis)
  • Your bones are too weak, which could cause the implant to shift or your bone to break
  • You have significant damage to the major network of nerves in your shoulder and arm (called the brachial plexus)
  • You do not have enough healthy bone in your upper arm or shoulder socket to properly support the implant
  • You have a disease affecting your nerves and muscles (confirm with trial site)
  • You have a known allergy to any of the materials used in the device
  • You have a condition that affects how your body forms bone (confirm with trial site)
  • You are currently pregnant
  • Your surgery is planned to be done in two separate stages

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 15 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Rebecca Gibson, Stryker Trauma

Phone: 901-232-2704

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Stryker Trauma and Extremities
Registry
ClinicalTrials.gov
Start date
12 September 2021
Est. completion
30 June 2036

Where this trial is recruiting

🇨🇦 Canada 🇫🇷 France 🇨🇭 Switzerland 🇬🇧 United Kingdom 🇺🇸 United States

Primary endpoints

Change from Baseline to last follow-up visit in ASES scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 15 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov